+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy



The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy



Clinical Nuclear Medicine 36(11): 997-1002



Single photon emission computed tomography (SPECT)/CT is emerging as a useful diagnostic tool in several oncological fields. In this prospective study, we assessed the usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of both residual breast tumors and axillary lymph node metastases following neoadjuvant therapy. Thirty-seven consecutive breast cancer patients scheduled to surgery following neoadjuvant therapy preoperatively underwent a Tc-99m-tetrofosmin SPECT/CT study, using a dual head gamma camera integrated with a x-ray tube for low-dose CT, including both breasts and axillary regions in the field of view. Within 1 week of SPECT/CT, all 37 patients had breast surgery with associated axillary lymph node dissection in 33/37 cases. At surgery, 31/37 patients had breast residues (microscopic in 4/31 cases and macroscopic in 27/31 cases). Axillary lymph node metastases were ascertained in 19/33 cases (N1mi: 2 cases, N1a: 8 cases, N2a: 6 cases, N2b: 3 cases). SPECT/CT sensitivity, specificity, and accuracy in detecting residual tumors were 87%, 100%, and 89.2%, respectively; the corresponding values in detecting axillary lymph node metastases were 36.8%, 92.8%, and 60.6%. SPECT/CT missed breast cancer residues in 4/31 patients, including 2 cases with microscopic residual disease. Moreover, lymph node metastases were missed in 12/19 patients (10/12 with pN1mi or pN1a metastases), all with lymph nodes with post-therapy fibrotic changes and small deposits of metastases. Tc-99m-tetrofosmin SPECT/CT proved a useful diagnostic tool in the detection and in the localization of residual breast tumors following neoadjuvant therapy. The procedure lacked in sensitivity in identifying axillary lymph node metastases, especially in patients with a limited lymph node involvement. According to our data, SPECT/CT may guide the surgeon to the most appropriate breast surgical treatment and to eventually select the most suitable axillary lymph node sampling (axillary lymph node dissection or sentinel node biopsy).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056530056

Download citation: RISBibTeXText

PMID: 21975387

DOI: 10.1097/RLU.0b013e3182291b59


Related references

99mTc-Tetrofosmin axillary planar, SPECT and pinhole-SPECT in breast cancer non palpable lymph node metastases detection. Journal of Nuclear Medicine 42(5 Supplement): 24P, 2001

The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection. Quarterly Journal of Nuclear Medicine 47(2): 116-128, 2003

Detection of Axillary Lymph Node Metastases and Extra-Axillary Metastases With FDG PET/CT in Breast Cancer Patients Scheduled for Neoadjuvant Chemotherapy. Practical Radiation Oncology 3(2 Suppl 1): S24-S25, 2014

Planar and SPECT Tc-99m MIBI and tetrofosmin in detecting axillary lymph-node metastases in breast cancer. Journal of Nuclear Medicine 40(5 SUPPL ): 138P, 1999

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: retrospective comparative evaluation of clinically axillary lymph node positive and negative patients, including those with axillary lymph node metastases confirmed by fine needle aspiration. Bmc Cancer 16(1): 808, 2016

Tc-99m tetrofosmin pinhole-SPECT in breast cancer axillary lymph node metastasis detection. Journal of Nuclear Medicine 40(5 SUPPL ): 249P, 1999

Detection of axillary lymph node metastases in breast cancer with Tc-99m tetrofosmin scintigraphy. International Journal of Oncology 20(3): 483-487, 2002

99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging. Cancer BioTherapy and Radiopharmaceuticals 16(6): 501-513, 2002

One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Annals of Surgical Oncology 23(1): 78-86, 2016

Risk Stratification For Axillary Lymph Node Metastases in Breast Cancer Patients: What Clinicopathological and Radiological Factors of Primary Breast Cancer Can Predict Preoperatively Axillary Lymph Node Metastases?. Ultrasound Quarterly 33(1): 15-22, 2016

TC-99M tetrofosmin pinhole-spect in breast cancer axillary lymph node staging. European Journal of Cancer 35(SUPPL 4): S206, Sept, 1999

The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer. Clinical Breast Cancer 2019, 2019

Usefulness of 99m-Tc-sestamibi scintimammography in suspected breast cancer and in axillary lymph node metastases detection. European Journal of Surgical Oncology 27(3): 256-259, 2001

Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation. International Journal of Clinical Oncology 18(3): 547-553, 2014

The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging. Cancer BioTherapy and Radiopharmaceuticals 15(1): 81-91, 2000